UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry

Molecular & cellular proteomics, 2015-12, Vol.14 (12), p.3105-3117

2015

Link zum Volltext

Verfügbarkeit prüfen

Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

The Journal of immunology (1950), 2017-10, Vol.199 (8), p.2639-2651

2017

Link zum Volltext

Verfügbarkeit prüfen

HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)

Proceedings of the National Academy of Sciences - PNAS, 2015-01, Vol.112 (2), p.E166-E175

2015

Link zum Volltext

Verfügbarkeit prüfen

The immunopeptidomic landscape of ovarian carcinomas

Proceedings of the National Academy of Sciences - PNAS, 2017-11, Vol.114 (46), p.E9942-E9951

2017

Link zum Volltext

Verfügbarkeit prüfen

Dipeptides promote folding and peptide binding of MHC class I molecules

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (38), p.15383-15388

2013

Link zum Volltext

Verfügbarkeit prüfen

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16), p.4627-4641

2018

Link zum Volltext

Verfügbarkeit prüfen

Dipeptides catalyze rapid peptide exchange on MHC class I molecules

Proceedings of the National Academy of Sciences - PNAS, 2015-01, Vol.112 (1), p.202-207

2015

Link zum Volltext

Verfügbarkeit prüfen

Cancer testis antigen Cyclin A1 harbors several HLA-A02:01-restricted T cell epitopes, which are presented and recognized in vivo

Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1217-1227

2020

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A02:01‑restricted T cell epitopes, which are presented and recognized in vivo

Cancer Immunology, Immunotherapy, 2021-10, Vol.70 (10), p.3055-3055

2021

Link zum Volltext

Verfügbarkeit prüfen

Chain-growth polyglycosylation: synthesis of linker-equipped mannosyl oligomers

Carbohydrate research, 2015-02, Vol.403, p.135-141

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Studies of Different Duocarmycin Based Glycosidic Prodrugs for Their Use in the Antibody-Directed Enzyme Prodrug Therapy

Journal of medicinal chemistry, 2009-01, Vol.52 (2), p.537-543

2009

Link zum Volltext

Verfügbarkeit prüfen

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Oncoimmunology, 2018-04, Vol.7 (4), p.e1316438

2018

Link zum Volltext

Verfügbarkeit prüfen

Duocarmycin-based prodrugs for cancer prodrug monotherapy

Bioorganic & medicinal chemistry, 2008-06, Vol.16 (12), p.6312-6318

2008

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the Canine MHC Class I DLA-8850101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy

PloS one, 2016-11, Vol.11 (11), p.e0167017-e0167017

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Evaluation of Prodrugs Based on the Natural Antibiotic Duocarmycin for Use in ADEPT and PMT

Chemistry : a European journal, 2011-02, Vol.17 (6), p.1922-1929

2011

Link zum Volltext

Verfügbarkeit prüfen

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues

iScience, 2022-02, Vol.25 (2), p.103768-103768, Article 103768

2022

Link zum Volltext

Verfügbarkeit prüfen

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Oncoimmunology, 2017-03, Vol.6 (3), p.e1219825-e1219825

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity

Organic & biomolecular chemistry, 2010-01, Vol.8 (8), p.1833-1842

2010

Link zum Volltext

Verfügbarkeit prüfen

Enantio- and Diastereoselective Synthesis of Duocarmycine-Based Prodrugs for a Selective Treatment of Cancer by Epoxide Opening

Chemistry : a European journal, 2008-01, Vol.14 (3), p.895-901

2008

Link zum Volltext

Verfügbarkeit prüfen

Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer Therapy

ChemMedChem, 2008-12, Vol.3 (12), p.1946-1955

2008

Link zum Volltext

Verfügbarkeit prüfen

Atropisomerism of Aromatic Carbamates

Chemistry : a European journal, 2010-11, Vol.16 (42), p.12678-12682

2010

Link zum Volltext

Verfügbarkeit prüfen

Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies

Molecular & cellular proteomics, 2020-03, Vol.19 (3), p.432-443

2020

Link zum Volltext

Verfügbarkeit prüfen

Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand

Molecular & cellular proteomics, 2021-01, Vol.20, p.100110-100110, Article 100110

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(124)
Japanisch
(16)
Deutsch
(4)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(54)
Humans
(50)
Immunotherapy
(21)
Peptides
(17)
Immunology
(15)
Female
(14)
Ligands
(14)
Oncology
(14)
Animals
(13)
Male
(13)
Biochemistry & Molecular Biology
(12)
Multidisciplinary Sciences
(12)
Science & Technology - Other Topics
(12)
Mass Spectrometry
(11)
Physical Sciences
(11)
Technology
(11)
Middle Aged
(10)
Aged
(9)
Cell Line, Tumor
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry

Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices

HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)

The immunopeptidomic landscape of ovarian carcinomas

An open-source computational and data resource to analyze digital maps of immunopeptidomes

Dipeptides promote folding and peptide binding of MHC class I molecules

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation

Dipeptides catalyze rapid peptide exchange on MHC class I molecules

Cancer testis antigen Cyclin A1 harbors several HLA-A02:01-restricted T cell epitopes, which are presented and recognized in vivo

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A02:01‑restricted T cell epitopes, which are presented and recognized in vivo

Chain-growth polyglycosylation: synthesis of linker-equipped mannosyl oligomers

Synthesis and Biological Studies of Different Duocarmycin Based Glycosidic Prodrugs for Their Use in the Antibody-Directed Enzyme Prodrug Therapy

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Duocarmycin-based prodrugs for cancer prodrug monotherapy

Characterization of the Canine MHC Class I DLA-8850101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy

Synthesis and Biological Evaluation of Prodrugs Based on the Natural Antibiotic Duocarmycin for Use in ADEPT and PMT

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity

Enantio- and Diastereoselective Synthesis of Duocarmycine-Based Prodrugs for a Selective Treatment of Cancer by Epoxide Opening

Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer Therapy

Atropisomerism of Aromatic Carbamates

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies

Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand

Suchergebnisse filtern